Who are it's competitors? Will it be another Biota who's product was not preferred bc the market liked tamiflu better.
On a positive note there is a big dividend coming up and this time it will be franked.
Offshore investors like oz biotech stocks that hAve made it . That is reached all milestones. So a definite long term take over prospect.
Not linked to economic conditions as such. That is when people need the product they will get it bc of illness . So it's shielded away from market volatility.
Trader chart is nice.
So it is investment grade.
I have been averaging up
bby increases acr target to $4.10, page-9
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.69M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 434 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 17258 | 1 |
View Market Depth
| Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable